Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - lösung zur injektion in einen stift ausgefüllt - tirzepatidum 12.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - lösung zur injektion in einen stift ausgefüllt - tirzepatidum 15 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 und 5.